Ironwood Pharmaceuticals (IRWD) Net Cash Flow Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | -62.71% |
| 10 | Ironwood Pharmaceuticals | 635.82 Mn | 415.35 Mn | - | -60.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.66% |
| Dec 31, 2025 | -3.07% |
| Sep 30, 2025 | -12.00% |
| Jun 30, 2025 | 44.79% |
| Mar 31, 2025 | 40.01% |
| Dec 31, 2024 | -80.75% |
| Sep 30, 2024 | -30.31% |
| Jun 30, 2024 | -31.89% |
| Mar 31, 2024 | -27.14% |
| Dec 31, 2023 | -32.95% |
| Sep 30, 2023 | -47.36% |
| Jun 30, 2023 | -202.12% |
| Mar 31, 2023 | 15.85% |
| Dec 31, 2022 | 37.77% |
| Sep 30, 2022 | 24.59% |
| Jun 30, 2022 | -42.86% |
| Mar 31, 2022 | 18.76% |
| Dec 31, 2021 | 32.30% |
| Sep 30, 2021 | 146.75% |
| Jun 30, 2021 | 146.27% |